87 Women’s acceptance of overdetection in breast cancer screening: can we assess harm-benefit trade-offs?

Anne Stiggelbout; Jolyn Hersch; Tessa Copp; Gert-Jan Liefers; Gemma Jacklyn; Jesse Jansen; Kirsten McCaffery

doi:10.1136/bmjebm-2018-111070.87

Article info

Oral presentations

87 Women’s acceptance of overdetection in breast cancer screening: can we assess harm-benefit trade-offs?

Authors

Anne Stiggelbout 1Leiden University Medical Center, The Netherlands PubMed articles Google scholar articles
Jolyn Hersch 2The University of Sydney, Australia PubMed articles Google scholar articles
Tessa Copp 2The University of Sydney, Australia PubMed articles Google scholar articles
Gert-Jan Liefers 1Leiden University Medical Center, The Netherlands PubMed articles Google scholar articles
Gemma Jacklyn 2The University of Sydney, Australia PubMed articles Google scholar articles
Jesse Jansen 2The University of Sydney, Australia PubMed articles Google scholar articles
Kirsten McCaffery 2The University of Sydney, Australia PubMed articles Google scholar articles

Citation

Stiggelbout A, Hersch J, Copp T, et al

87 Women’s acceptance of overdetection in breast cancer screening: can we assess harm-benefit trade-offs?

BMJ Evidence-Based Medicine 2018;23:A41.

Publication history

First published August 20, 2018.

Online issue publication

January 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password